A new article by researchers from the University of Michigan and Johns Hopkins builds on a growing body of scientific literature that indicates that cannabinoids can serve as an effective pain reliever for some people and as a replacement for some pharmaceutical drugs.
The cross-sectional study, published last week in the Journal of the American Medical Association (JAMA), included data from 1,724 adults aged 18 and over living in 36 states plus Washington and DC from March to April 2022.
It turned out that more than half of the adults who used cannabis for chronic pain reported that it led to a reduction in the use of prescription opioid and other pain relievers. Only less than one percent of respondents reported that cannabis use increased the use of these drugs, according to the authors in a research article that received federal funding through the National Institute on Drug Abuse.
NORML Deputy Director Paul Armentano commented on the results, stating in a blog post Friday that cannabis has "established efficacy in the treatment of multiple conditions, including chronic pain, and has a safety profile that is either comparable to or superior to other controlled substances." He also noted that the expansion of legal access to cannabis will lead to an even greater effect of replacing opioid painkillers in the future.